Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: billkirn who wrote (2289)	10/12/1997 3:32:00 PM
From: JOHN W.	of 6136

For all: Where does the concept of "capitulation" by the shorts fit into the near future. RS&C pointed to this buying support/momentum and used the word "capitulation". I would think that this is a very dangerous time for any hedge fund manager with a large short position, due the the large amount of positives ahead that could be released, especially European approval (that is expected in this quarter). If the upward momentum continues toward the low 60s as every day passes the European approval announcement becomes a little closer, yes very dangerous. If Nations Sec. has a 1% position also, what is the likelihood that crossen switches back toward "buy" or "strong buy" as European approval approaches and more data is released on Viracept at hamburg... These are the days.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next